Regulation (EC) No 273/2004, as amended by this Regulation, envisages the processing of information, including the processing of personal data, for the purposes of enabling the competent authorities to monitor the placing on the market of drug precursors and to prevent the diversion of scheduled substances. The processing of personal data should be carried out in a manner compatible with the purpose of that Regulation and in accordance with Directive 95/46/EC of the European Parliament and of the Council [Directive 95/46/EC of the European Parliament and of the Council of 24 October 1995 on the protection of individuals with regard to the processing of personal data and on the free movement of such data (OJ L 281, 23.11.1995, p. 31).] and Regulation (EC) No 45/2001 of the European Parliament and of the Council [Regulation (EC) No 45/2001 of the European Parliament and of the Council of 18 December 2000 on the protection of individuals with regard to the processing of personal data by the Community institutions and bodies and on the free movement of such data (OJ L 8, 12.1.2001, p. 1).] and, in particular, with Union requirements relating to data quality, proportionality, purpose limitation, and rights to information, access, rectification of data, erasure and blocking, organisational and technical measures and international transfers of personal data.
Recital 10, Regulation (EU) No 1258/2013 of the European Parliament and of the Council of 20 Novembe…
In forcesince 20 Nov 2013
Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11 February…Law
- celex=31995L0046
- celex=31995R0046
- celex=32001R0045
- num:eu=1945/2001
- num:eu=1995/46